Iteos Therapeutics Inc (ITOS)
$10.02 $0.06 (0.67%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$383.48M -
Day's Range
$9.59 - $9.92 -
Volume
704,982 -
52 Week Low / High
$8.20 - $18.75 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
ITOS's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $39.50
- Target Price
Company News
-
iTeos Announces 2024 Strategic Priorities and Anticipated Milestones — Jan 8th, 2024
iTeos Therapeutics Inc. - TIGIT program clinical data readouts anticipated in 2024, including two Phase 2 trials assessing belrestotug + dostarlimab in 1L NSCLC and 1L HNSCC - Adenosine portfolio clinical data readouts anticipated in second half of 2024, including inupadenant’s Phase 2...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$